Skip to main content

Advertisement

SpringerLink
Log in

Selenium Nanoparticles Induce the Chemo-Sensitivity of Fluorouracil Nanoparticles in Breast and Colon Cancer Cells

  • Published:
Biological Trace Element Research Aims and scope Submit manuscript

Abstract

Drug resistance is a major challenge of breast and colon cancer therapies leading to treatment failure. The main objective of the current study is to investigate whether selenium nanoparticles (nano-Se) can induce the chemo-sensitivity of 5-fluorouracil (FU)-encapsulated poly (D, L-lactide-co-glycolide) nanoparticles (nano-FU) in breast and colon cancer cell lines. Nano-Se and nano-FU were synthesized and characterized, then applied individually or in combination upon MCF7, MDA-MB-231, HCT 116, and Caco-2 cancerous cell lines. Cytotoxicity, cellular glucose uptake, and apoptosis, as well as malondialdehyde (MDA), nitric oxide (NO), and zinc (Zn) levels, were investigated upon the different treatments. We have resulted that nano-FU induced cell death in MCF7 and Caco-2 more effectively than MDA-MB-231 and HCT 116 cell lines. Moreover, nano-FU plus nano-Se potentiate MCF7 and Caco-2 chemo-sensitivity were higher than MDA-MB-231 and HCT 116 cancerous cell lines. It is relevant to note that Se and FU nano-formulations inhibited cancer cell bioenergetics via glucose uptake slight blockage. Furthermore, nano-FU increased the levels of NO and MDA in media over cancer cells, while their combinations with nano-Se rebalance the redox status with Zn increment. We noticed that MCF7 cell line is sensitive, while MDA-MB-231 cell line is resistant to Se and nano-Se. This novel approach could be of great potential to enhance the chemo-sensitivity in breast and colon cancer cells.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6
Fig. 7
Fig. 8

Similar content being viewed by others

References

  1. Kotepui M (2016) Diet and risk of breast cancer. Contemp Oncol (Pozn) 20:13–19. https://doi.org/10.5114/wo.2014.40560

    Article  CAS  Google Scholar 

  2. Longley DB, Harkin DP, Johnston PG (2003) 5-fluorouracil: mechanisms of action and clinical strategies. Nat Rev Cancer 3:330–338. https://doi.org/10.1038/nrc1074

    Article  CAS  PubMed  Google Scholar 

  3. Afzal S, Jensen SA, Vainer B, Vogel U, Matsen JP, Sorensen JB, Andersen PK, Poulsen HE (2009) MTHFR polymorphisms and 5-FU-based adjuvant chemotherapy in colorectal cancer. Ann Oncol 20:1660–1666. https://doi.org/10.1093/annonc/mdp046

    Article  CAS  PubMed  Google Scholar 

  4. Canman CE, Tang HY, Normolle DP, Lawrence TS, Maybaum J (1992) Variations in patterns of DNA damage induced in human colorectal tumor cells by 5-fluorodeoxyuridine: implications for mechanisms of resistance and cytotoxicity. Proc Natl Acad Sci U S A 89:10474–10478 https://www.ncbi.nlm.nih.gov/pubmed/?term=Canman+CE%2C+Tang+HY%2C+Normolle+DP%2C+Lawrence+TS%2C+Maybaum+J.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  5. de Gramont A, Figer A, Seymour M, Homerin M, Hmissi A, Cassidy J, Boni C, Cortes-Funes H, Cervantes A, Freyer G, Papamichael D, Le Bail N, Louvet C, Hendler D, de Braud F, Wilson C, Morvan F, Bonetti A (2000) Leucovorin and fluorouracil with or without oxaliplatin as first-line treatment in advanced colorectal cancer. J Clin Oncol 18:2938–2947. https://doi.org/10.1200/JCO.2000.18.16.2938

    Article  PubMed  Google Scholar 

  6. Boige V, Mendiboure J, Pignon JP, Loriot MA, Castaing M, Barrois M, Malka D, Tregouet DA, Bouche O, Le Corre D, Miran I, Mulot C, Ducreux M, Beaune P, Laurent-Puig P (2010) Pharmacogenetic assessment of toxicity and outcome in patients with metastatic colorectal cancer treated with LV5FU2, FOLFOX, and FOLFIRI: FFCD 2000–05. J Clin Oncol 28:2556–2564. https://doi.org/10.1200/JCO.2009.25.2106

    Article  CAS  PubMed  Google Scholar 

  7. Abd-Rabou AA, Bharali DJ, Mousa SA (2018) Taribavirin and 5-Flurouracil-loaded Pegylated-lipid nanoparticle synthesis, p38 docking, and Antiproliferative effects on MCF-7 breast Cancer. Pharm Res (In Press) 35:76. https://doi.org/10.1007/s11095-017-2283-3

    Article  CAS  Google Scholar 

  8. Xue X, Liang XJ (2012) Overcoming drug efflux-based multidrug resistance in cancer with nanotechnology. Chin J Cancer 31:100–109. https://doi.org/10.5732/cjc.011.10326

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  9. Dixon JM (2014) Endocrine resistance in breast Cancer. New J Sci 2014:1–27. https://doi.org/10.1155/2014/390618

    Article  CAS  Google Scholar 

  10. Huang CY, Yu LCH (2015) Pathophysiological mechanisms of death resistance in colorectal carcinoma. World J Gastroenterol 21:11777–11792. https://doi.org/10.3748/wjg.v21.i41.11777

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  11. Księżakowska-Łakoma K, Żyła M, Wilczyński JR (2014) Mitochondrial dysfunction in cancer. PrzMenopauzalny 13:136–144. https://doi.org/10.5114/pm.2014.42717

    Article  CAS  Google Scholar 

  12. Zhong W, Oberley TD (2001) Redox-mediated effects of selenium on apoptosis and cell cycle in the LNCaP human prostate cancer cell line. Cancer Res 61:7071–7078 https://www.ncbi.nlm.nih.gov/pubmed/11585738

    CAS  PubMed  Google Scholar 

  13. Schrauzer GN (2009) Selenium and selenium-antagonistic elements in nutritional cancer prevention. Crit Rev Biotechnol 29:10–17. https://doi.org/10.1080/07388550802658048

    Article  CAS  PubMed  Google Scholar 

  14. Luo H, Yang Y, Huang F, Li F, Jiang Q, Shi K, Xu C (2012) Selenite induces apoptosis in colorectal cancer cells via AKT-mediated inhibition of β-catenin survival axis. Cancer Lett 315:78–85. https://doi.org/10.1016/j.canlet.2011.10.014

    Article  CAS  PubMed  Google Scholar 

  15. Fernandes AP, Gandin V (2015) Selenium compounds as therapeutic agents in cancer. Biochim Biophys Acta 1850:1642–1660. https://doi.org/10.1016/j.bbagen.2014.10.008

    Article  CAS  PubMed  Google Scholar 

  16. Sanmartín C, Plano D, Sharma AK, Palop JA (2012) Selenium compounds, apoptosis and other types of cell death: an overview for cancer therapy. Int J Mol Sci 13:9649–9672. https://doi.org/10.3390/ijms13089649

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  17. Gupta S, Jaworska-Bieniek K, Lubinski J, Jakubowska A (2013) Can selenium be a modifier of cancer risk in CHEK2 mutation carriers? Mutagenesis 28:625–629. https://doi.org/10.1093/mutage/get050

    Article  CAS  PubMed  Google Scholar 

  18. Zhang J, Wang H, Bao Y, Zhang L (2004) Nano red elemental selenium has no size effect in the induction of seleno-enzymes in both cultured cells and mice. Life Sci 75:237–244. https://doi.org/10.1016/j.lfs.2004.02.004

    Article  CAS  PubMed  Google Scholar 

  19. Gulyas G, Csosz E, Prokisch J, Javor A, Mezes M, Erdelyi M, Balogh K, Janaky T, Szabo Z, Simon A, Czegledi L (2016) Effect of nano-sized, elemental selenium supplement on the proteome of chicken liver. J Anim Physiol Anim Nutr (Berl) 101:502–510. https://doi.org/10.1111/jpn.12459

    Article  CAS  Google Scholar 

  20. Yu B, Li X, Zheng W, Feng Y, Wong YS, Chen T (2014) pH-responsive cancer-targeted selenium nanoparticles: a transformable drug carrier with enhanced theranostic effects. J Mater Chem B 2:5409–5418. https://doi.org/10.1039/C4TB00399C

    Article  CAS  PubMed  Google Scholar 

  21. Zheng S, Li X, Zhang Y, Xie Q, Wong YS, Zheng W, Chen T (2012) PEG-nanolized ultrasmall selenium nanoparticles overcome drug resistance in hepatocellular carcinoma HepG2 cells through induction of mitochondria dysfunction. Int J Nanomedicine 7:3939–3949. https://doi.org/10.2147/IJN.S30940.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  22. Abd-Rabou AA, Ahmed HH (2017) CS-PEG decorated PLGA nano-prototype for delivery of bioactive compounds: a novel approach for induction of apoptosis in HepG2 cell line. Advances in medical sciences. Adv Med Sci 62:357–367. https://doi.org/10.1016/j.advms.2017.01.003.

    Article  PubMed  Google Scholar 

  23. Shalby AB, Abd-Rabou AA, Ahmed HH (2017) Nano-se crosstalks with nano-DOX/FU to selectively hack hepatic cancer cells and spare normal cells healthy: a mechanism-based study. J Appl Pharm Sci 7(8):003–012. https://doi.org/10.7324/JAPS.2017.70802 http://www.japsonline.com

    Article  CAS  Google Scholar 

  24. Zhang JS, Gao XY, Zhang LD, Bao YP (2001) Biological effects of a nano red elemental selenium. Biofactors 15:27–38 https://www.ncbi.nlm.nih.gov/pubmed/11673642

    Article  PubMed  Google Scholar 

  25. Parveen S, Sahoo SK (2011) Long circulating chitosan/PEG blended PLGA nanoparticle for tumor drug delivery. Eur J Pharmacol 670:372–383. https://doi.org/10.1016/j.ejphar.2011.09.023

    Article  CAS  PubMed  Google Scholar 

  26. van Meerloo J, Kaspers GJ, Cloos J (2011) Cell sensitivity assays: the MTT assay. Methods Mol Biol 731:237–245. https://doi.org/10.1007/978-1-61779-080-5_20.

    Article  PubMed  Google Scholar 

  27. Brigelius-Floh’e R, Lötzer K, Maurer S, Schultz M, Leist M (1996) Utilization of selenium from different chemical entities for selenoproteinbiosymthesis by mammalian cell lines. Biofactors 5:125–131 https://www.ncbi.nlm.nih.gov/pubmed?term=Utilization%20of%20selenium%20from%20different%20chemical%20entities%20for%20selenoproteinbiosymthesis%20by%20mammalian%20cell%20lines,%20BioFactors[all]&cmd=correctspelling

    Google Scholar 

  28. Combs GF, Garbisu C, Yee BC, Yee A, Carlson DE, Smith NR, Magyarosy AC, Leighton T, Buchanan BB (1996) Bioavailability of selenium accumulated by selenite-reducing bacteria. Biol Trace Elem Res 52:209–225. https://doi.org/10.1007/BF02789163

    Article  CAS  PubMed  Google Scholar 

  29. Ghadi FE, Ghara AR, Bhattacharyya S, Dhawan DK (2009) Selenium as a chemopreventive agent in experimentally induced colon carcinogenesis. World J Gastrointest Oncol 1:74–81. https://doi.org/10.4251/wjgo.v1.i1.74

    Article  PubMed  PubMed Central  Google Scholar 

  30. Abd-Rabou AA, Assirey EA, Saad R, Ibrahim HS (2018) Metallocenes-induced apoptosis in human hepatic cancer HepG2 cells: the prodigy of zamzam water. Int J Pharmacol 14:260–270

    Article  Google Scholar 

  31. Dong Y, Ganther HE, Stewart C, Ip C (2002) Identification of molecular targets associated with selenium-induced growth inhibition in human breast cells using cDNA microarrays. Cancer Res 62:708–714 https://www.ncbi.nlm.nih.gov/pubmed/?term=Identification+of+molecular+targets+associated+with+selenium-induced+growth+inhibition+in+human+breast+cells+using+cDNA+microarrays.+Cancer+Res

    CAS  PubMed  Google Scholar 

  32. Sanmartín C, Plano D, Palop JA (2008) Selenium compounds and apoptotic modulation: a new perspective in cancer therapy. Mini Rev Med Chem 8:1020–1031 https://www.ncbi.nlm.nih.gov/pubmed/?term=Selenium+compounds+and+apoptotic+modulation%3A+a+new+perspective+in+cancer+therapy.+Mini+Rev+Med+Chem

    Article  PubMed  Google Scholar 

  33. Ahmed HH, Khalil WK, Hamza AH (2014) Molecular mechanisms of Nano-selenium in mitigating hepatocellular carcinoma induced by N-nitrosodiethylamine (NDEA) in rats. Toxicol Mech Methods 24:593–602. https://doi.org/10.3109/15376516.2014.956912

    Article  CAS  PubMed  Google Scholar 

  34. Ruseva B, Atanasova M, Tsvetkova R, Betova T, Mollova M, Alexandrova M, Laleva P, Dimitrova A (2015) Effect of Selenium Supplementation on Redox Status of the Aortic Wall in Young Spontaneously Hypertensive Rats. Effect of Selenium Supplementation on Redox Status of the Aortic Wall in Young Spontaneously Hypertensive Rats Oxid Med Cell Longev 2015:609053–609010. https://doi.org/10.1155/2015/609053

    Article  CAS  PubMed  Google Scholar 

  35. Yeo JK, Cha SD, Cho CH, Kim SP, Cho JW, Baek WK, Suh MH, Kwon TK, Park JW, Suh SI (2002) Se-methylselenocysteine induces apoptosis through caspase activation and Bax cleavage mediated by calpain in SKOV-3 ovarian cancer cells. Cancer Lett 182:83–92 https://www.ncbi.nlm.nih.gov/pubmed?term=se%20methyl%20selenocysteine%20induces%20apoptosis%20through%20caspase%20activation%20and%20bax%20cleavage%20mediated%20by%20calpain%20in%20skov-3%20ovarian%20cancer%20cells.%20cancer%20lett.&cmd=correctspelling

    Article  CAS  PubMed  Google Scholar 

  36. Christensen MJ, Nartey ET, Hada AL, Legg RL, Barzee BR (2007) High selenium reduces NF-kappaB-regulated gene expression in uninduced human prostate cancer cells. Nutr Cancer 58:197–204. https://doi.org/10.1080/01635580701328701

    Article  CAS  PubMed  Google Scholar 

  37. Nadiminty N, Gao AC (2008) Mechanisms of selenium chemoprevention and therapy in prostate cancer. Mol Nutr Food Res 52:1247–1260. https://doi.org/10.1002/mnfr.200700369

    Article  CAS  PubMed  Google Scholar 

  38. Saifo MS, Rempinski DR Jr, Rustum YM, Azrak RG (2010) Targeting the oncogenic protein beta-catenin to enhance chemotherapy outcome against solid human cancers. Mol Cancer 9:310. https://doi.org/10.1186/1476-4598-9-310

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  39. Favaro E, Bensaad K, Chong MG, Tennant DA, Ferguson DJ, Snell C, Steers G, Turley H, Li JL, Gunther UL, Buffa FM, McIntyre A, Harris AL (2012) Glucose utilization via glycogen phosphorylase sustains proliferation and prevents premature senescence in cancer cells. Cell Metab 16:751–764. https://doi.org/10.1016/j.cmet.2012.10.017

    Article  CAS  PubMed  Google Scholar 

  40. Jackson MI, Jr CGF (2008) Selenium and anticarcinogenesis: underlying mechanisms. Curr Opin Clin Nutr Metab Care 11:718–726. https://doi.org/10.1097/MCO.0b013e3283139674

    Article  CAS  PubMed  Google Scholar 

  41. Xiao H, Jiang Y, Qi Y, Zhou X, Gong C, Huang C, Li M (2012) Effects of selenium and zinc on the proliferation of human esophageal cancer cell line studied by serophysiology. Wei Sheng Yan Jiu 41:185–190 https://www.ncbi.nlm.nih.gov/pubmed/?term=Zhou+X%2C+Gong+C%2C+Huang+C%2C+Li+M.+Effects+of+selenium+and+zinc+on+the+proliferation+of+human+esophageal+cancer+cell+line+studied+by+serophysiology.+Wei+Sheng+Yan+Jiu

    CAS  PubMed  Google Scholar 

  42. Yu RA, Xia T, Wang AG, Chen XM (2006) Effects of selenium and zinc on renal oxidative stress and apoptosis induced by fluoride in rats. Biomed Environ Sci 19(6):439–444 https://www.ncbi.nlm.nih.gov/pubmed/?term=Wang+AG%2C+Chen+XM.+Effects+of+selenium+and+zinc+on+renal+oxidative+stress+and+apoptosis+induced+by+fluoride+in+rats.+Biomed+Environ+Sci

    CAS  PubMed  Google Scholar 

  43. Lunyin Y, Dong X, Hanqiao L (1996) Influence of zinc, managenese and selenium on superoxide dismutase activity in lung cancer tissue and cell in culture. Chin J Cancer Res 8(1):42–45

    Article  Google Scholar 

  44. Liu T, Zeng L, Jiang W, Fu Y, Zheng W, Chen T (2015) Rational design of cancer-targeted selenium nanoparticles to antagonize multidrug resistance in cancer cells. Nanomedicine 11:947–958. https://doi.org/10.1016/j.nano.2015.01.009

    Article  CAS  PubMed  Google Scholar 

  45. Jia X, Liu Q, Zou S, Xu X, Zhang L (2015) Construction of selenium nanoparticles/β-glucan composites for enhancement of the antitumor activity. Carbohydr Polym 117:434–442. https://doi.org/10.1016/j.carbpol.2014.09.088

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Hormones Department, Medical Research Division, National Research Centre, P.O. 12622, Dokki, Giza, Egypt

    Ahmed A. Abd-Rabou, Aziza B. Shalby & Hanaa H. Ahmed

Authors
  1. Ahmed A. Abd-Rabou
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Aziza B. Shalby
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Hanaa H. Ahmed
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Hanaa H. Ahmed.

Ethics declarations

Conflict of Interest

The authors declare no conflict of interests.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Abd-Rabou, A.A., Shalby, A.B. & Ahmed, H.H. Selenium Nanoparticles Induce the Chemo-Sensitivity of Fluorouracil Nanoparticles in Breast and Colon Cancer Cells. Biol Trace Elem Res 187, 80–91 (2019). https://doi.org/10.1007/s12011-018-1360-8

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12011-018-1360-8

Keywords

Search

Navigation